S. Bott
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Diabetes Management and Research 6
- Diabetes Treatment and Management 2
- Diabetes Management and Education 1
-
- Inhalation and Respiratory Drug Delivery 2
- Infection Control and Ventilation 1
- Co-authors
- Tim Heise (8 shared papers)Michael Berger (2 shared papers)U. Bott (2 shared papers)Ingrid Mühlhauser (1 shared paper)Lutz Heinemann (5 shared papers)Klaus Rave (4 shared papers)Susan Willavize (1 shared paper)Sue Sha (1 shared paper)
- Journals
- Diabetic Medicine (3 papers)Diabetes Care (2 papers)Hormone and Metabolic Research (1 paper)Experimental and Clinical Endocrinology & Diabetes (1 paper)Diabetes Technology & Therapeutics (1 paper)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
S. Bott
9 papers receiving 423 citations
Peers
Comparison fields: 5 of 46
- Endocrinology, Diabetes and Metabolism 342
- Pulmonary and Respiratory Medicine 125
- Pharmaceutical Science 23
- Genetics 85
- Surgery 113
Countries citing papers authored by S. Bott
This map shows the geographic impact of S. Bott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bott more than expected).
Fields of papers citing papers by S. Bott
This network shows the impact of papers produced by S. Bott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bott. The network helps show where S. Bott may publish in the future.
Co-authors
The 22 scholars most cited alongside S. Bott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 134 | |
| 2 | 2005 | 132 | |
| 3 | 2005 | 64 | |
| 4 | 2002 | 51 | |
| 5 | 2000 | 33 | |
| 6 | 2006 | 32 | |
| 7 | 2005 | 13 | |
| 8 | 2004 | 10 | |
| 9 | 2005 | 7 | |
| 10 | No evidence for accumulation of HOE901 after multiple injections in type I diabetic patients | 2000 | 2 |
About S. Bott
S. Bott is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Surgery, Clinical Biochemistry and Genetics, having authored 10 papers that have together received 478 indexed citations. Recurring topics across this work include Diabetes Management and Research (6 papers), Inhalation and Respiratory Drug Delivery (2 papers), Diabetes Treatment and Management (2 papers), Infection Control and Ventilation (1 paper), Advanced Glycation End Products research (1 paper), Diabetes and associated disorders (1 paper), Diabetes Management and Education (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (342 citations), Pulmonary and Respiratory Medicine (125 citations), Pharmaceutical Science (23 citations), Genetics (85 citations) and Surgery (113 citations). S. Bott has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Tim Heise, Michael Berger, U. Bott, Ingrid Mühlhauser, Lutz Heinemann, Klaus Rave, Susan Willavize, Sue Sha, R. H. A. Becker and R. Roßkamp. Their work appears in journals such as Diabetic Medicine, Diabetes Care, Hormone and Metabolic Research, Experimental and Clinical Endocrinology & Diabetes and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.